Trump's generic drug tariff plan introduces a phased import duty that could reach 200% within three years, encouraging pharmaceutical companies to manufacture in the United States. The proposal could significantly affect India's pharmaceutical industry, which supplies nearly 40% of generic medicines used in the US. Trump Generic Drug Tariffs Target India Pharma Export
Trump's generic drug tariff plan introduces a phased import duty that could reach 200% within three years, encouraging pharmaceutical companies to manufacture in the United States. The proposal could significantly affect India's pharmaceutical industry, which supplies nearly 40% of generic medicines used in the US. Trump Generic Drug Tariffs Target India Pharma Export